CPT Code: 82088
Order Code: 17181
ABN Requirement: No
Specimen:
Preferred: Serum
Alternative: EDTA Plasma
Volume: 1.0 mL
Minimum Volume: 0.25 mL
Container:
Preferred: Red Top Tube (no gel barrier)
Alternative: Lavender Top Tube (EDTA)
Collection:
Serum:
- Collect and label sample according to standard protocols.
- Gently invert tube 5 times immediately after draw. Do not shake.
- Allow blood to clot 30 minutes.
- Centrifuge for 10 minutes.
- Aliquot serum into transport tube labeled as “Red Top Serum” and cap tightly. Discard original tube.
EDTA Plasma:
- Collect and label sample according to standard protocols.
- Gently invert tube 10 times immediately after draw. Do not shake.
- Centrifuge specimen for 10 minutes.
- Aliquot plasma into transport tube labeled as “EDTA Plasma” and cap tightly. Discard original tube.
Collection Instructions: Serum separator tubes are unacceptable. Draw blood in a no-additive (red-top) tube. Separate serum after clotting. Draw “upright” samples at least 1/2 hour after patient sits up.
Transport: Store serum or EDTA plasma at 2°C to 8°C after collection and ship the same day per packaging instructions included with the provided shipping box.
Stability:
Ambient (15-25°C): 4 days
Refrigerated (2-8°C): 7 days
Frozen (-20°C): 28 days
Causes for Rejection: Specimens other than serum; improper labeling; samples not stored properly; samples older than stability limits; samples collected in SST tubes; moderate to gross hemolysis.
Methodology: Chromatography/Mass Spectrometry
Turn Around Time: 4 to 7 days
Reference Ranges:
| Adult | |
| Upright 8:00-10:00 AM | ≤28 ng/dL |
| Upright 4:00-6:00 PM | ≤21 ng/dL |
| Supine 8:00-10:00 AM | 3-16 ng/dL |
| Pediatric | |
| 1-12 Months | 2-70 ng/dL |
| 1-4 Years | 2-37 ng/dL |
| 5-9 Years | ≤9 ng/dL |
| 10-13 Years | ≤21 ng/dL |
| 14-17 Years | ≤35 ng/dL |
| Infants | |
| Premature (31-35 Weeks) | ≤144 ng/dL |
| Term | ≤217 ng/dL |
| Tanner Stages | |
| II-III Males | 1-13 ng/dL |
| II-III Females | 2-20 ng/dL |
| IV-V Males | 3-14 ng/dL |
| IV-V Females | 4-32 ng/dL |
Clinical Significance: Approximately 1-2% of individuals with primary hypertension have primary hyperaldosteronism characterized by hypokalemia (low potassium) and low direct renin. Serum aldosterone concentrations vary due to dietary sodium intake and whether the patient is upright or supine (body position).
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.